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Arterial Stiffness
Retinal Microvasculature in Relation to Central
Hemodynamics in a Flemish Population
Fang-Fei Wei, Lutgarde Thijs, Cai-Guo Yu, Jesus D. Melgarejo, Zhen-Yu Zhang,
Gladys E. Maestre, Harry A.J. Struijker-Boudier, Peter Verhamme, Jan A. Staessen
Abstract—Arterial stiffness and wave reflection predict cardiovascular mortality and morbidity and are associated with renal
microvascular disease. We hypothesized that the retinal microvascular traits might be associated with central hemodynamic
properties. In 735 randomly recruited Flemish (mean age, 50.3 years; 47.1% women), we derived central pulse pressure
and carotid-femoral pulse wave velocity by applanation tonometry and calculated forward (Pf) and backward (Pb) pulse
waves, using an automated pressure-based wave separation algorithm. We measured central retinal arteriolar (CRAE) and
venular equivalent and their ratio, using IVAN software (Vasculomatic ala Nicola, version 1.1). Mean values for pulse
wave velocity (n=554), Pf and Pb were 7.50 m/s, 32.0 mm Hg, and 21.5 mm Hg, respectively. In multivariable-adjusted
analyses, CRAE was 4.62 µm and 1.26 µm smaller (P≤0.034) for a 1-SD increment in central mean arterial pressure (+11.3
mm Hg) and central pulse pressure (+15.2 mm Hg); a 1-SD increment in the augmentation ratio (+7.0%), aortic pulse wave
velocity (+1.66 m/s), Pf (+10.0 mm Hg), and Pb (+8.5 mm Hg), was associated with smaller CRAE; the association sizes
were −1.91 µm, −1.59 µm, −1.45 µm, and −2.38 µm (P≤0.014), respectively. Associations of arteriole-to-venule diameter
ratio with the central hemodynamic traits mirrored those of CRAE. None of the multivariable-adjusted associations of
central retinal venular diameter with the central hemodynamic traits reached significance with the exception of central
diastolic blood pressure (−1.62 µm; P=0.030). In conclusion, in the general population, higher central pulse pressure,
pulse wave velocity, Pf, and Pb were associated with smaller CRAE.  (Hypertension. 2019;74:606-613. DOI: 10.1161/
HYPERTENSIONAHA.119.13255.) Online Data Supplement

•
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T

he mechanical and functional properties of blood vessels, including arterial stiffness and wave reflection,
predict cardiovascular complications over and beyond traditional risk factors.1–6 The arterial pressure wave consists of
a forward component generated by the heart and reflected
waves returning from peripheral branching sites to the central aorta.7–9 In stiff compared with elastic arteries, reflected
waves return faster, reach the proximal aorta during systole,
and augment late systolic blood pressure.10 Aortic pulse wave
velocity (PWV) is the gold standard in the assessment of arterial stiffness.11
The observation that retinal microvascular diameters predict cardiovascular mortality,12 coronary heart disease,13 and
lacunar stroke,14 extended research from the macrocirculation to the microcirculation. The brain is continually perfused

at high volume flow throughout systole and diastole, so that
pulsations are transmitted through the capillary network up to
the venous efflux.15 The retina shares similar embryological
origin, anatomic features, and physiological properties with
cerebral microvasculature.16 Nonmydriatic retinal photography allows noninvasive visualization of the retinal microvasculature in population surveys.17–19 Few studies addressed
the association between the retinal microcirculation and the
properties of the large arteries20–24 but are difficult to interpret, because they cannot be generalized to the general population,21,23 because they involved brachial-ankle PWV and
thereby encompassed both elastic and muscular arteries,22,24 or
because they had a small sample size.21,23 Our literature review
did not reveal any previous study that addressed the possible
association of retinal microvascular traits with the forward

Received April 24, 2019; first decision May 7, 2019; revision accepted June 5, 2019.
From the Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, Department of Cardiovascular Sciences,
University of Leuven, Leuven, Belgium (F.-F.W., L. T., C.-G.Y., J.D.M., Z.-Y.Z., J.A.S.); Department of Endocrinology, Beijing Luhe Hospital and Key
Laboratory of Diabetes Prevention and Research, Capital Medical University, Beijing, China (C.-G.Y); Department of Neurosciences and Department of
Human Genetics, University of Texas Rio Grande Valley School of Medicine, Brownsville, TX (G.E.M.); Department of Pharmacology (H.A.J.S.-B.) and
Cardiovascular Research Institute Maastricht (CARIM) (J.A.S.), Maastricht University, The Netherlands; and Centre for Molecular and Vascular Biology,
Department of Cardiovascular Sciences, University of Leuven, Belgium (P.V.).
This paper was sent to David Calhoun, Guest Editor, for review by expert referees, editorial decision, and final disposition.
The online-only Data Supplement is available with this article at https://www.ahajournals.org/doi/suppl/10.1161/HYPERTENSIONAHA.119.13255.
Correspondence to Fang-Fei Wei, Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department
of Cardiovascular Sciences, University of Leuven, Campus Sint Rafaël, Kapucijnenvoer 35, Box 7001, BE-3000 Leuven, Belgium. Email fangfei.wei@
kuleuven.be
© 2019 The Authors. Hypertension is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access
article under the terms of the Creative Commons Attribution Non-Commercial-NoDerivs License, which permits use, distribution, and reproduction in any
medium, provided that the original work is properly cited, the use is noncommercial, and no modifications or adaptations are made.
Hypertension is available at https://www.ahajournals.org/journal/hyp

606

DOI: 10.1161/HYPERTENSIONAHA.119.13255

Wei et al   Retinal Microvasculature and Central Hemodynamics   607
and backward components of the aortic pulse wave.20–24 We
addressed this knowledge gap by analyzing data from the
FLEMENGHO (Flemish Study on Environment, Genes, and
Health Outcomes).25

Methods
Study Population
FLEMENGHO complies with the Helsinki declaration for research
in humans.26 The Ethics Committee of the University Hospitals
Leuven approved the protocol. The data, analytic methods, and
study materials will not be made available to other researchers for
purposes of reproducing the results or replicating the procedure,
because informed consent did not cover this option. FLEMENGHO
is a longitudinal family based population study, which enrolled
3343 individuals from 1985 until 2004.25 Participants were repeatedly followed-up. At each contact, participants gave or renewed
informed written consent. The participation rate was 78.0% at
enrollment and 76.0% for retinal photography (2008−2015).
Surviving participants, who still lived in the catchment area of the
study (North Limburg, Belgium), who were not hospitalized or institutionalized, and who had undergone both retinal photography
(2008−2015) and a tonometric assessment of their central hemodynamics (2005−2015) were eligible for the current analysis. Of 1027
eligible participants, we excluded 292 from analysis if retinal photographs were of too low quality to be reliably graded (n=187) or
if the quality of the pulse wave analysis (n=60) or wave separation
analysis (n=45) was substandard. Therefore, our current analysis
included 735 participants.

Clinical and Biochemical Measurements
Participants were asked to refrain from heavy exercise, smoking,
drinking alcohol, or caffeine-containing beverages for at least 3 hours
before being examined. Study nurses administered validated questionnaires, inquiring into each participant’s medical history, smoking and alcohol intake, intake of medications, and lifestyle. Body
mass index was calculated as body weight in kilograms divided by
height in meters squared. Fasting blood samples were analyzed for
plasma glucose and serum total cholesterol, using automated enzymatic methods in a single certified laboratory. Diabetes mellitus was
defined as a fasting plasma glucose of 7.0 mmol/L (126 mg/dL) or
higher or use of antidiabetic agents.

Hemodynamic Measurements
After the participants had rested for at least 5 minutes in the supine position, nurses measured blood pressures twice to the nearest
2 mm Hg on the right arm, using a standard mercury sphygmomanometer (Riester GmbH, Jungingen, Germany) fitted with the appropriate cuff size according to European guidelines.27 The second of the
2 measurements was analyzed and used for calibration of the pulse
wave analysis. Hypertension was defined as a brachial blood pressure
of at least 140 mm Hg systolic or 90 mm Hg diastolic or use of antihypertensive drugs. Pulse pressure was systolic minus diastolic blood
pressure. Mean arterial pressure was diastolic pressure plus 40% of
pulse pressure.28
Next, experienced observers (F.-F. Wei and Z.-Y. Zhang) recorded during an 8-second period, the radial arterial waveform at the
dominant arm by applanation tonometry. They used a high-fidelity
SPC-301 micromanometer (Millar Instruments Inc, Houston, TX) interfaced with a laptop computer running the SphygmoCor software
(AtCor Medical Pty Ltd, West Ryde, New South Wales, Australia),
version 9.0. Recordings were discarded when blood pressure variability of consecutive waveforms exceeded 5% or the amplitude
of the pulse wave signal was <80 mV. From the radial signal, the
SphygmoCor software calculates the aortic pulse wave by means of
a validated generalized transfer function.29,30 The software returns the
central systolic, diastolic and pulse pressure, and the pressure at the
first and second peak (shoulder) of the central waveform (Figure S1 in
the online-only Data Supplement). The augmentation ratio and index

are quotients of the second over the first peak of the central blood
pressure wave and of the absolute difference between the second and
first peak over central pulse pressure, both expressed as a percentage.
From the central waveform, a triangular-flow pressure-based wave
separation algorithm,31 as implemented in the SphygmoCor software,
allows computing the forward and backward pulse pressure amplitudes (Figure S1) and the timing of their peak height relative to the
electrocardiographic QRS complex. The reflection index was the ratio of the backward to the forward pulse pressure amplitude expressed
as percentage.
In 554 participants, aortic PWV was measured by sequential
electrocardiographically gated recordings of the arterial pressure waveform at the carotid and femoral arteries. The observers
measured the distance from the suprasternal notch to the carotid
sampling site (distance A) and from the suprasternal notch to the
femoral sampling site (distance B). Pulse wave travel distance was
calculated as distance B minus distance A.32 Pulse transit time was
the average of 10 consecutive beats.11 Carotid-femoral PWV is the
ratio of the travel distance in meters to transit time in seconds.
PWV was discarded if the SEM of 10 beats was >10%. We standardized the augmentation ratio and index, the aortic PWV, the
forward and backward wave amplitudes and peak times to a heart
rate of 65 beats per minute (approximately the mean in the study
population).

Retinal Photography
We applied a nonmydriatic approach in a dimly lit room to acquire
retinal photographs, one image per eye in each participant, with
the Canon Cr-DGi retinal visualization system combined with the
Canon D 50 digital camera (Canon Inc, Medical Equipment Group,
Utsunomiya, Japan). After centering the image on the optic disk, we
measured the central retinal arteriolar (CRAE) and venular (CRVE)
equivalent, which represent the retinal arteriolar and venular diameter. We used the validated computer-assisted programme IVAN
(Vasculomatic ala Nicola, version 1.1, Department of Ophthalmology
and Visual Science, University of Wisconsin-Madison, Madison, WI)
based on formulae published by Parr and Spears33 and Hubbard et
al.34 The IVAN software returns average vessel diameters according
to the revised Knudtson formula.35 The arteriole-to-venule diameter
ratio (AVR) was CRAE divided by CRVE. For analysis, we averaged each participant’s measurements at both eyes. Intraobserver variability according to the Bland and Altman method36 was 11.7% for
CRAE, 9.6% for CRVE, and 12.5% for AVR.18 The corresponding
estimates for interobserver variability were 10.8%, 9.9%, and 14.6%,
respectively.18

Statistical Analysis
For database management and statistical analysis, we used SAS software, version 9.4 (SAS Institute Inc, Cary, NC). We compared means
and proportions by the large-sample Z test or ANOVA and by the χ2
statistic, respectively. Statistical significance was a 2-sided significance of 0.05.
In exploratory analyses, we plotted the retinal arteriolar diameter by quartiles of the distributions of forward and backward
wave amplitudes and aortic PWV. In unadjusted and multivariable-adjusted analyses, we expressed association sizes of the
retinal phenotypes for a 1-SD increment in the central hemodynamic measurements. As in previous publications,37 we adjusted
for sex, age, body mass index, heart rate, serum total cholesterol,
plasma glucose, current smoking (0, 1) and alcohol intake (0, 1),
use of antihypertensive drugs (0, 1), and history of cardiovascular
disease (0, 1), and additionally brachial diastolic blood pressure
for the time-dependent central hemodynamic measurements, including the augmentation ratio and index, PWV, the forward and
backward amplitudes, and the reflection magnitude. Sensitivity
analyses excluding those on antihypertensive drug treatment were
performed to assess the association between CRAE and all central
hemodynamic measurements. In sensitivity analyses, the models
relating CRAE to the central hemodynamic measurements were
additionally adjusted for CRVE to provide unbiased results.38
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Table 1. Characteristics of Participants

Women
(n=346)

Characteristics

Table 2.

Men (n=389)

All (n=735)

All patients in category

Central Hemodynamics and Retinal Microvascular Traits

Characteristics
Systolic pressure, mm Hg

Women
(n=346)

Men
(n=389)

All
(n=735)

121.1±18.6

127.1±16.3*

124.3±17.7

 Smokers

39 (11.3)

64 (16.4)*

103 (14.0)

Diastolic pressure, mm Hg

77.3±9.2

82.5±9.6*

80.0±9.8

 Drinking alcohol

79 (22.8)

222 (57.1)†

301 (41.0)

94.8±11.5

100.4±10.4*

97.7±11.3

 Hypertension

116 (33.5)

187 (48.1)†

303 (41.2)

Mean arterial pressure,
mm Hg

 Antihypertensive treatment

68 (19.6)

90 (23.1)

158 (21.5)

Central pulse pressure,
mm Hg

43.8±15.5

44.6±15.0

44.2±15.2

  Diuretics

26 (7.5)

28 (7.2)

54 (7.4)

9.7±8.6*

11.1±8.5

44 (12.7)

43 (11.0)

87 (11.8)

Augmentation pressure,
mm Hg

12.7±8.2

  β-blockers
  ACE inhibitors or ARBs

18 (5.2)

38 (9.8)*

56 (7.6)

Augmentation ratio, %

111.6±6.4

107.8±6.7*

109.6±6.8

  CCBs or α-blockers

12 (3.5)

37 (9.5)‡

49 (6.7)

Augmentation index, %

28.2±10.9

21.5±11.1*

24.7±11.5

 Diabetes mellitus

13 (3.8)

21 (5.4)

34 (4.6)

Pulse wave velocity, m/s

7.13±1.63

7.81±1.63*

7.49±1.66

 History of cardiovascular
disease

10 (2.9)

23 (5.9)*

33 (4.5)

Forward pulse peak time,
ms

104.6±12.2

109.1±14.0*

107.0±13.4

Backward pulse peak
time, ms

238.0±18.2

228.5±20.7*

233.0±20.1

Forward wave amplitude,
mm Hg

30.3±9.6

33.4±10.2*

31.9±10.0

Mean (SD) of characteristic
 Age, y
 Body mass index, kg/m

2

 Brachial SBP, mm Hg

49.5±15.1

51.1±14.8

50.3±15.0

25.9±4.4

27.0±3.7†

26.5±4.1

124.8±17.6 130.4±14.7† 127.8±16.4

20.8±8.3

21.3±8.3

76.5±9.1

81.7±9.5†

79.2±9.7

Backward wave amplitude,
mm Hg

21.9±8.3

 Brachial DBP, mm Hg
 Heart rate, bpm

66.0±9.3

61.9±8.3†

63.9±9.0

Reflection magnitude, %

71.9±17.2

64.4±18.4*

67.9±18.2

 Serum total cholesterol,
mmol/L

5.04±0.88

4.89±0.92*

4.96±0.90

Central retinal arteriolar
diameter, µm

152.8±14.3

149.1±14.1*

150.8±14.3

 Serum HDL cholesterol,
mmol/L

1.62±0.36

1.31±0.29†

1.45±0.36

Central retinal venular
diameter, µm

220.6±19.4

217.9±18.1

219.2±18.8

 Plasma glucose, mmol/L

4.75±0.63

4.92±0.69†

4.84±0.67

Arteriole-to-venule
diameter ratio

0.70±0.09

0.69±0.06

0.69±0.07

Brachial blood pressure was the second of 2 measurements in the supine
position. Hypertension was a brachial blood pressure of ≥140 mm Hg systolic
or ≥90 mm Hg diastolic or use of antihypertensive drugs. Diabetes mellitus
was fasting plasma glucose of ≥126 mg/dL (7.0 mmol/L) or use of antidiabetic
agents. ACE indicates angiotensin-converting enzyme; ARB, angiotensinreceptor blockers; CCBs, calcium-channel blockers; DBP, diastolic blood
pressure; HDL, high-density lipoprotein; and SBP, systolic blood pressure.
Significance of the sex difference:
*P≤0.05.
†P≤0.001.
‡P≤0.01.

Results
Characteristics of Participants
All 735 participants were white Europeans, of whom 346
(47.1%) were female. In all participants, mean values (±SD)
were 50.3±15.0 years for age, 26.5±4.1 kg/m2 for body mass
index, and 127.8±16.4/79.2±9.7 mm Hg for systolic/diastolic blood pressure. Of 303 participants with hypertension,
158 were on antihypertensive drug treatment (52.1%) with
diuretics (n=54 [34.2%]), β-blockers (n=87 [55.1%]), inhibitors of the renin-angiotensin system (angiotensin-converting
enzyme inhibitors or angiotensin II type-1 receptor blockers;
n=56 [35.4%]) or vasodilators (calcium-channel blockers or
α-blockers; n=49 [31.0%]), prescribed in varying combinations in 70 patients (44.3%). Thirty-four participants (4.6%)
had diabetes mellitus.

Values are means±SD. The analyses included 735 participants with the
exception of pulse wave velocity, which was available in only 554 subjects. The
time-dependent hemodynamic variables (augmentation ratio and index, pulse
wave velocity, and the forward and backward peak times and wave amplitudes)
were standardized to a heart rate of 65 beats per minute (approximately the
mean in the study population).
Significance of the sex difference:
*P≤0.001.

Tables 1 and 2 list the clinical, hemodynamic, and retinal microvascular characteristics of the participants by sex.
Compared with women, men had a higher prevalence of
smoking, alcohol intake, and hypertension and had significantly higher body mass index, blood pressure, and plasma
glucose (P≤0.043; Table 1). Mean values for aortic PWV
(n=554) and the forward and backward wave amplitudes were
7.50±1.66 m/s, 32.0±10.1 mm Hg, and 21.5±8.5 mm Hg, respectively. Compared with women, men had significantly
(P<0.001) higher central systolic and diastolic blood pressure,
aortic PWV and forward wave amplitude but lower augmentation pressure, augmentation ratio and index, reflection magnitude, and smaller CRAE (Table 2).

Unadjusted Analyses
The Figure demonstrates that in unadjusted analyses, the
CRAE decreased across quartiles of the distributions of the
forward and backward wave amplitudes and aortic PWV. In
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Figure. Central retinal arteriolar diameter
(CRAE) by quartiles of the distribution of
forward wave amplitude (Pf), backward wave
amplitude (Pb), and aortic pulse wave velocity
(PWV, n=554). Each plotted point represents the
unstandardized and unadjusted mean. Vertical
bars indicate the SE. P values are for linear
trend across the quartiles by Pf (A), Pb (B), and
PWV (C).

unadjusted analyses (Table 3), the CRAE was inversely associated with all central hemodynamic measurements with
association sizes for a 1-SD increment in the explanatory
hemodynamic variables (P≤0.009) ranging from −5.97 µm
(mean arterial pressure) to −1.38 µm (forward wave amplitude). The CRVE significantly (P≤0.030) decreased with all
central hemodynamic measurements (Table S1 and Figure S2)
with the exception of the forward wave amplitude (P=0.72).
The associations of the AVR with the central hemodynamic
traits were directionally similar compared with the CRAE but
were weaker for the augmentation ratio and index and the reflection magnitude (Table 4 and Figure S3).

Adjusted Analyses
With adjustments applied for sex, age, body mass index, heart
rate, serum total cholesterol, plasma glucose, current smoking and alcohol intake, antihypertensive drug treatment, and
history of cardiovascular disease, a 1-SD increment in central mean pressure (+11.3 mm Hg), pulse pressure (+15.2
mm Hg), and augmentation pressure (+8.5 mm Hg) was associated with smaller CRAE (P≤0.034; Table 3) with association sizes amounting to −4.62, −1.26, and −2.81 µm,

respectively. Additionally adjusted for brachial diastolic blood
pressure, for a 1-SD increment in the augmentation ratio (+7.0
%), aortic PWV (+1.66 m/s), and the forward (+10.0 mm Hg)
and backward (+8.5 mm Hg) wave amplitudes, the association
sizes with CRAE were −1.91, −1.59, −1.45, and −2.38 µm
(P≤0.030), respectively (Table 3). None of the multivariableadjusted associations of the CRVE with the central hemodynamic traits reached significance (P≥0.22; Table S1) with
the exception of central diastolic blood pressure (P=0.030).
The multivariable-adjusted associations of AVR with the
central hemodynamic variables mirrored those of the CRAE
(Table 4). They were nonsignificant for the augmentation
index, aortic PWV, and the reflection magnitude (Table 4;
P≥0.34). The association sizes of the AVR with the other central hemodynamic traits were significant (P≤0.037; Table 4)
with association sizes ranging from −0.018 (central mean arterial pressure) to −0.008 (forward wave amplitude).

Sensitivity Analyses
Multivariable-adjusted analyses stratified by median age
(≤50.8 versus >50.8 years; Table S2) generated results
similar to those reported in Table 3. Among 577 untreated

Table 3. Central Retinal Arteriolar Diameter in Relation to Central Hemodynamics

Unadjusted Models
Hemodynamics (+1 SD)

Estimate (95% CI)

Adjusted Models
P Value

Estimate (95% CI)

P Value

Central systolic pressure (+17.7 mm Hg)

–5.28 (–6.25 to –4.32)

<0.001

–3.88 (–5.05 to –2.70)

<0.001

Central diastolic pressure (+9.8 mm Hg)

–5.09 (–6.06 to –4.12)

<0.001

–3.94 (–4.99 to –2.90)

<0.001

Central mean pressure (+11.3 mm Hg)

–5.97 (–6.91 to –5.02)

<0.001

–4.62 (–5.73 to –3.51)

<0.001

Central pulse pressure (+15.2 mm Hg)

–2.86 (–3.88 to –1.84)

<0.001

–1.26 (–2.42 to –0.09)

0.034

Augmentation pressure (+8.5 mm Hg)

–3.56 (–4.56 to –2.55)

<0.001

–2.81 (–4.34 to –1.27)

<0.001

Augmentation ratio (+7.0%)

–2.89 (–3.91 to –1.87)

<0.001

–1.91 (–3.43 to –0.39)

0.014

Augmentation index (+11.6%)

–2.58 (–3.60 to –1.56)

<0.001

–0.48 (–1.85 to 0.89)

0.50

Pulse wave velocity (+1.66 m/s)

–4.25 (–5.33 to –3.18)

<0.001

–1.59 (–3.02 to –0.16)

0.030

Forward wave amplitude (+10.0 mm Hg)

–1.38 (–2.41 to –0.35)

0.009

–1.45 (–2.44 to –0.45)

0.004

Backward wave amplitude (+8.5 mm Hg)

–3.38 (–4.39 to –2.37)

<0.001

–2.38 (–3.59 to –1.17)

<0.001

Reflection magnitude (+18.2%)

–2.60 (–3.62 to –1.58)

<0.001

–0.78 (–2.10 to 0.54)

0.24

Association sizes (95% CI) express the difference in central retinal arteriolar diameter associated with 1-SD increment in the hemodynamic
indexes. The analyses included 735 participants with the exception of pulse wave velocity, which was available in only 554 subjects. Adjusted models
accounted for sex, age, body mass index, heart rate, serum total cholesterol, plasma glucose, smoking and alcohol intake, use of antihypertensive
drugs, and history of cardiovascular disease. The augmentation ratio and index, pulse wave velocity, forward and backward wave amplitudes, and
reflection magnitude were also adjusted for brachial diastolic blood pressure.
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Table 4. Arteriole-to-Venule Diameter Ratio in Relation to Hemodynamic Traits

Unadjusted Models
Hemodynamics (+ 1 SD)

Adjusted Models

Estimate (95% CI)

P Value

Estimate (95% CI)

P Value

Central systolic pressure (+17.7 mm Hg)

–0.016 (–0.021 to –0.010)

<0.001

–0.017 (–0.024 to –0.011)

<0.001

Central diastolic pressure (+9.8 mm Hg)

–0.016 (–0.022 to –0.011)

<0.001

–0.014 (–0.019 to –0.008)

<0.001

Central mean pressure (+11.3 mm Hg)

–0.018 (–0.024 to –0.013)

<0.001

–0.018 (–0.024 to –0.012)

<0.001

Central pulse pressure (+15.2 mm Hg)

–0.008 (–0.013 to –0.002)

0.006

–0.009 (–0.015 to –0.002)

0.008

Augmentation pressure (+8.5 mm Hg)

–0.007 (–0.013 to –0.002)

0.009

–0.013 (–0.022 to –0.005)

0.002

Augmentation ratio (+7.0%)

–0.005 (–0.010 to 0.001)

0.096

–0.009 (–0.018 to –0.001)

0.037

Augmentation index (+11.6%)

–0.005 (–0.010 to 0.001)

0.083

–0.004 (–0.011 to 0.004)

0.36

Pulse wave velocity (+1.66 m/s)

–0.008 (–0.013 to –0.003)

0.001

–0.003 (–0.010 to 0.003)

0.34

Forward wave amplitude (+10.0 mm Hg)

–0.005 (–0.011 to 0.0001)

0.055

–0.008 (–0.014 to –0.002)

0.005

Backward wave amplitude (+8.5 mm Hg)

–0.008 (–0.013 to –0.002)

0.006

–0.012 (–0.018 to –0.005)

0.001

Reflection magnitude (+18.2%)

–0.004 (–0.009 to 0.002)

0.16

–0.003 (–0.010 to 0.004)

0.41

Association sizes (95% CI) express the difference in retinal arteriole-to-venule diameter ratio associated with 1-SD increment in the
hemodynamic indexes. The analyses included 735 participants with the exception of pulse wave velocity, which was available in only 554
subjects. Adjusted models accounted for sex, age, body mass index, heart rate, serum total cholesterol, plasma glucose, smoking and alcohol
intake, use of antihypertensive drugs, and history of cardiovascular disease. The augmentation ratio and index, pulse wave velocity, forward and
backward wave amplitudes, and reflection magnitude were also adjusted for brachial diastolic blood pressure.

participants, 432 had normal blood pressure. Sensitivity
analyses of retinal microvascular traits in relation to the central hemodynamics in participants not on antihypertensive
drug treatment (Tables S3 and S4) and in those with normal
blood pressure (Table S3) were confirmatory. Similarly, excluding 34 participants with diabetes mellitus produced confirmatory results (Table S5).
Next, we ran an analysis of the central hemodynamics
calibrated by diastolic blood pressure and mean arterial
pressure, defined as diastolic blood pressure plus one-third
of pulse pressure (Table S6). Correlation coefficients of the
central hemodynamic measurements calibrated in this alternative way with those derived by the recommended calibration were all higher than 0.986. Consequently, there were no
material differences between the association sizes in Table S6
and Table 3. The same was true when models relating CRAE
to the central hemodynamic measurements were additionally
adjusted for CRVE (Table S7), although with a marginally
trend of inverse association between CRAE and aortic PWV
(P=0.072) and with a significant association with the augmentation index (P<0.001).

Discussion
To our knowledge, our study is the first population survey
assessing the association of retinal microvascular traits with
central hemodynamic measurements. The key finding of our
study was that the CRAE was smaller with higher values of
aortic PWV, central pulse pressure, augmentation ratio, and
the forward and backward wave amplitudes. There is close
anatomic proximity between the central arteries and the retinal arterioles. The ophthalmic artery branches directly from
the internal carotid artery. The inverse association of the retinal arteriolar diameter with central hemodynamic indexes
reflecting arterial stiffness is, therefore, coherent and physiologically plausible. Indeed, in a stiffer arterial tree, the

backward wave returns during systole, thus augmenting central systolic blood pressure and widening central pulse pressure. The pulsatile stress on the wall of the large arteries leads
to further degradation of the elastin fibers, so that extremely
stiff collagen increasingly bears the pulsatile load.39
Several studies investigated the association between the
central retinal microvascular diameter and aortic stiffness
in hypertensive patients.21,23 In 3425 participants (46.4%
women; mean age, 62.0 years) enrolled in the Multi-Ethnic
Study of Atherosclerosis, aortic distensibility was determined from chest magnetic resonance imaging.20 With
adjustments applied for demographic variables and cardiovascular risk factors, participants in the lowest quartile
of the distribution of aortic distensibility, compared with
those in top quartile, had an increased risk of retinal arteriolar narrowing (odds ratio, 1.72; 95% CI, 1.15–2.58).20 In
multivariable-adjusted analyses of 137 never-treated early
stage hypertensive patients and 86 normotensive individuals
(36.3% women; mean age, 43.8 years),21 0.098 m/s higher
PWV and a 0.113 higher augmentation index were associated
with a 1-µm decrease in the CRAE diameter (P≤0.049).21 In
181 hypertensive patients (44.8% women; mean age, 53.9
years; treated for hypertension, 60.2%), the CRAE was significantly and inversely associated with the tonometrically
assessed aortic PWV in an unadjusted model (β=−0.228;
P<0.001). This association remained significant in multivariable-adjusted analyses (β=−0.233; P<0.001).23 Aortic PWV
was also measured over 24 hours, using Mobil-O-Graph
24-hour PWA monitors (IEM GmbH, Stolberg, Germany).40
The correlations of the CRAE with PWV measured over 24
hours and during wakefulness and sleep ranged from −0.241
to −0.204 in unadjusted analyses and from −0.292 to −0.222
in multivariable-adjusted models.23
Recent studies reported associations of the renal41 or
cerebral42,43 microvasculature with PWV. The Age, Gene/
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Environment Susceptibility-Reykjavik Study41 enrolled 629
randomly selected community-dwelling elderly 629 (45.2%
women; mean age 74.8 years), which were followed-up for
5.3 years (mean). In multivariable-adjusted models, a 1-SD
increment in the baseline carotid-femoral PWV and carotid
pulse pressure, predicted a decline in the estimated glomerular filtration rate at follow-up, amounting to 0.23 mL/min
per 1.73 m2 per year and 0.25 mL/min per 1.73 m2 per year,
respectively.41 With adjustments applied, higher PWV was
also associated with greater volume of white matter hyperintensity (β=0.108 mL; P=0.018) and lower memory scores
(β=−0.095; P=0.028) in multivariable-adjusted model.42
A meta-analysis of summary statistics extracted from 3
cross-sectional and 4 longitudinal studies and one study with
mixed design addressed the association between intelligence
quotient, a potential marker of the cerebral microcirculation,44 and PWV in participants older than 30 years without
comorbidities.43 Cognitive impairment was associated with
higher PWV.43 Previous studies demonstrated that retinal
venular diameter predicts the risk of stroke.45 However,
among 8794 participants (54.6% women; mean age, 60.0
years) of the Atherosclerosis Risk in Communities study, the
CRAE and CRVE were differentially associated with cardiovascular risk factors.46 The venular calibers were correlated
with cigarette smoking, blood pressure, biomarkers of systemic inflammation, and body mass index, whereas the main
correlate of the arteriolar diameters was blood pressure.46
Thus, association sizes of the venular diameters with cardiovascular risk factors are bound to differ between population
studies based on their prevalence, thereby explaining the null
association of venular diameters with the central hemodynamics in our multivariable-adjusted models (Table S1).
The current study must be interpreted within the context
of its strength and potential limitations. Strengths of our study
include its relatively large-sample size, population-based design, robust measurements for aortic stiffness, and a validated
computer-based technique to quantify retinal vascular caliber.
Our observations are in line with the literature and provide
an external validation of our study. Among 4926 participants
(56% women; age range, 43–84 years) enrolled in the Beaver
Dam Eye Study, retinal arteriolar diameters were in multivariable-adjusted analyses 2.1 µm (95% CI, 1.5–2.7) lower for
each decade increase in age, and 4.4 µm (95% CI, 3.8–5.0)
lower for each 10 mm Hg increase in mean arterial blood
pressure.47 In our study, the corresponding estimates were
1.5 µm (95% CI, 0.74–2.25) and 4.3 µm (95% CI, 3.3–5.3),
respectively. Furthermore, in line with common knowledge,
the central pressure augmentation was higher in women than
men as a result of shorter stature,7 differences in the ventricular contraction pattern,48 and morphology of the forward and
backward wave.49 Among the potential limitations of our current study is its cross-sectional design, which precludes direct
causal inferences. Furthermore, our current findings in white
Flemish cannot be extrapolated to other ethnicities. Finally,
292 of 1027 eligible participants (28.4%) were excluded from
the current analysis. However, participants analyzed and not
analyzed had similar body mass index, brachial diastolic
blood pressure, and plasma glucose (P≥0.13) but were on
average 6.7 years older and, therefore, had a slightly higher

systolic blood pressure and serum total cholesterol (P≤0.013;
Table S8).
The kidney and brain share unique susceptibilities to vascular injury, because they are continually perfused at high
volume flow throughout systole and diastole, so that pulsations are transmitted through the capillary network up to the
venous efflux.15 The cerebral microvasculature and the retinal microcirculation also share similar anatomic features
and physiological properties.16 The retina offers a unique
window to the brain.16 The clinical perspective of our current
study should be gauged from this point of view. Our study
thereby provides further insight on the crosstalk between microcirculation and macrocirculation in health and disease, as
mechanistically described in the seminal article published by
O’Rourke and Safar.15

Perspectives
For long clinicians focused on the macrocirculation because over the past 30 years invasive therapies were developed allowing effectively treating patients with acute
coronary syndrome, myocardial infarction, ischemic or hemorrhagic stroke, or peripheral arterial disease. These invasive approaches preserve vital organs and save lives. Only
recently, the insight grew that microcirculatory dysfunction is
a main driver of age-related chronic disease, including worsening diastolic left ventricular function,50 chronic kidney disease,41 and cognitive decline.42,43 Our current observations
highlight that dysfunction of the macrocirculation and microcirculation go hand in hand and suggest that the timely prevention of both macrovascular and microvascular alterations
could have relevant clinical impact.

Acknowledgments
We gratefully acknowledge the clerical assistance of Vera De
Leebeeck and Renilde Wolfs.

Sources of Funding
The European Union (HEALTH-F7-305507-HOMAGE), the
European Research Council (Advanced Researcher Grant
2011-294713-EPLORE and Proof-of-Concept Grant 713601-uPROPHET), the European Research Area Net for Cardiovascular
Diseases (JTC2017-046-PROACT), and the Research Foundation
Flanders, Ministry of the Flemish Community, Brussels, Belgium
(G.0881.13) supported the Studies Coordinating Centre in Leuven.

Disclosures
None.

References
1. Willum-Hansen T, Staessen JA, Torp-Pedersen C, Rasmussen S,
Thijs L, Ibsen H, Jeppesen J. Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation.
2006;113:664–670. doi: 10.1161/CIRCULATIONAHA.105.579342
2. Mitchell GF, Hwang SJ, Vasan RS, Larson MG, Pencina MJ, Hamburg NM,
Vita JA, Levy D, Benjamin EJ. Arterial stiffness and cardiovascular
events: the Framingham Heart Study. Circulation. 2010;121:505–511.
doi: 10.1161/CIRCULATIONAHA.109.886655
3. Wang KL, Cheng HM, Sung SH, Chuang SY, Li CH, Spurgeon HA,
Ting CT, Najjar SS, Lakatta EG, Yin FC, Chou P, Chen CH. Wave reflection and arterial stiffness in the prediction of 15-year all-cause and
cardiovascular mortalities: a community-based study. Hypertension.
2010;55:799–805. doi: 10.1161/HYPERTENSIONAHA.109.139964
4. Ben-Shlomo Y, Spears M, Boustred C, et al. Aortic pulse wave velocity
improves cardiovascular event prediction: an individual participant

612  Hypertension  September 2019

5.

6.

7.

8.

9.

10.

11.

12.

13.

14.

15.

16.

17.

18.

19.

20.

21.

22.

meta-analysis of prospective observational data from 17,635 subjects.
J Am Coll Cardiol. 2014;63:636–646. doi: 10.1016/j.jacc.2013.09.063
Zamani P, Jacobs DR Jr, Segers P, Duprez DA, Brumback L,
Kronmal RA, Lilly SM, Townsend RR, Budoff M, Lima JA, Hannan P,
Chirinos JA. Reflection magnitude as a predictor of mortality: the MultiEthnic Study of Atherosclerosis. Hypertension. 2014;64:958–964. doi:
10.1161/HYPERTENSIONAHA.114.03855
Zamani P, Lilly SM, Segers P, Jacobs DR Jr, Bluemke DA, Duprez DA,
Chirinos JA. Pulsatile load components, resistive load and incident heart
failure: the Multi-Ethnic Study of Atherosclerosis (MESA). J Card Fail.
2016;22:988–995. doi: 10.1016/j.cardfail.2016.04.011
Mitchell GF, Parise H, Benjamin EJ, Larson MG, Keyes MJ,
Vita JA, Vasan RS, Levy D. Changes in arterial stiffness and wave
reflection with advancing age in healthy men and women: the
Framingham Heart Study. Hypertension. 2004;43:1239–1245. doi:
10.1161/01.HYP.0000128420.01881.aa
Segers P, Rietzschel ER, De Buyzere ML, Vermeersch SJ, De Bacquer D,
Van Bortel LM, De Backer G, Gillebert TC, Verdonck PR; Asklepios
Investigators. Noninvasive (input) impedance, pulse wave velocity, and
wave reflection in healthy middle-aged men and women. Hypertension.
2007;49:1248–1255. doi: 10.1161/HYPERTENSIONAHA.106.085480
Vasan RS. Pathogenesis of elevated peripheral pulse pressure: some
reflections and thinking forward. Hypertension. 2008;51:33–36. doi:
10.1161/HYPERTENSIONAHA.107.101196
Zieman SJ, Melenovsky V, Kass DA. Mechanisms, pathophysiology, and
therapy of arterial stiffness. Arterioscler Thromb Vasc Biol. 2005;25:932–
943. doi: 10.1161/01.ATV.0000160548.78317.29
Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D,
Pannier B, Vlachopoulos C, Wilkinson I, Struijker-Boudier H; European
Network for Non-invasive Investigation of Large Arteries. Expert consensus
document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006;27:2588–2605. doi: 10.1093/eurheartj/ehl254
Wong TY, Klein R, Nieto FJ, Klein BE, SharrettAR, Meuer SM, Hubbard LD,
Tielsch JM. Retinal microvascular abnormalities and 10-year cardiovascular mortality: a population-based case-control study. Ophthalmology.
2003;110:933–940. doi: 10.1016/S0161-6420(03)00084-8
Wong TY, Klein R, Sharrett AR, Duncan BB, Couper DJ, Tielsch JM,
Klein BE, Hubbard LD. Retinal arteriolar narrowing and risk of coronary
heart disease in men and women. The Atherosclerosis Risk in Communities
Study. JAMA. 2002;287:1153–1159.
Yatsuya H, Folsom AR, Wong TY, Klein R, Klein BE, Sharrett AR;
ARIC Study Investigators. Retinal microvascular abnormalities and risk
of lacunar stroke: Atherosclerosis Risk in Communities Study. Stroke.
2010;41:1349–1355. doi: 10.1161/STROKEAHA.110.580837
O’Rourke MF, Safar ME. Relationship between aortic stiffening
and microvascular disease in brain and kidney: cause and logic
of therapy. Hypertension. 2005;46:200–204. doi: 10.1161/01.HYP.
0000168052.00426.65
Cheung CY, Ikram MK, Chen C, Wong TY. Imaging retina to study
dementia and stroke. Prog Retin Eye Res. 2017;57:89–107. doi: 10.1016/j.
preteyeres.2017.01.001
Wong TY, Klein R, Sharrett AR, Duncan BB, Couper DJ, Klein BE,
Hubbard LD, Nieto FJ; Atherosclerosis Risk in Communities Study.
Retinal arteriolar diameter and risk for hypertension. Ann Intern Med.
2004;140:248–255. doi: 10.7326/0003-4819-140-4-200402170-00006
Liu YP, Richart T, Jin Y, Struijker-Boudier HA, Staessen JA. Retinal arteriolar and venular phenotypes in a Flemish population: reproducibility
and correlates. Artery Res. 2011;5:72–79.
Cheung CY, Ikram MK, Sabanayagam C, Wong TY. Retinal microvasculature as a model to study the manifestations of hypertension.
Hypertension. 2012;60:1094–1103. doi: 10.1161/HYPERTENSIONAHA.
111.189142
Cheung N, Sharrett AR, Klein R, Criqui MH, Islam FM, Macura KJ,
Cotch MF, Klein BE, Wong TY. Aortic distensibility and retinal arteriolar narrowing: the multi-ethnic study of atherosclerosis. Hypertension.
2007;50:617–622. doi: 10.1161/HYPERTENSIONAHA.107.091926
Triantafyllou A, Anyfanti P, Gavriilaki E, Zabulis X, Gkaliagkousi E,
Petidis K, Triantafyllou G, Gkolias V, Pyrpasopoulou A, Douma S.
Association between retinal vessel caliber and arterial stiffness in a population comprised of normotensive to early-stage hypertensive individuals. Am
J Hypertens. 2014;27:1472–1478. doi: 10.1093/ajh/hpu074
Lin F, Zhu P, Huang F, Li Q, Yuan Y, Gao Z, Yu P, Lin J, Chen F. Aortic
stiffness is associated with the central retinal arteriolar equivalent and
retinal vascular fractal dimension in a population along the southeastern
coast of China. Hypertens Res. 2015;38:342–348. doi: 10.1038/hr.2015.11

23. Aissopou EK, Argyris AA, Nasothimiou EG, Konstantonis GD, Tampakis K,
Tentolouris N, Papathanassiou M, Theodossiadis PG, Papaioannou TG,
Stehouwer CD, Sfikakis PP, Protogerou AD. Ambulatory aortic stiffness
is associated with narrow retinal arteriolar caliber in hypertensives: the
SAFAR Study. Am J Hypertens. 2016;29:626–633. doi: 10.1093/ajh/hpv145
24. Kawashima-Kumagai K, Tabara Y, Yamashiro K, Setoh K, Yoshikawa M,
Kawaguchi T, Miyake M, Nakanishi H, Muraoka Y, Takahashi Y, Kosugi S,
Nakayama T, Yoshimura N, Matsuda F, Tsujikawa A; Nagahama Study
Group. Association of retinal vessel calibers and longitudinal changes in
arterial stiffness: the Nagahama study. J Hypertens. 2018;36:587–593.
doi: 10.1097/HJH.0000000000001602
25. Wei FF, Zhang ZY, Thijs L, Yang WY, Jacobs L, Cauwenberghs N, Gu YM,
Kuznetsova T, Allegaert K, Verhamme P, Li Y, Struijker-Boudier HA,
Staessen JA. Conventional and ambulatory blood pressure as predictors
of retinal arteriolar narrowing. Hypertension. 2016;68:511–520. doi:
10.1161/HYPERTENSIONAHA.116.07523
26. World Medical Association. World Medical Association Declaration of
Helsinki. Ethical principles for medical research involving human subjects. JAMA.. 2013;310:2191–2194. doi: 10.1001/jama.2013.281053
27. O’Brien E, Asmar R, Beilin L, et al; European Society of Hypertension
Working Group on Blood Pressure Monitoring. European Society of
Hypertension recommendations for conventional, ambulatory and home
blood pressure measurement. J Hypertens. 2003;21:821–848. doi:
10.1097/01.hjh.0000059016.82022.ca
28. Bos WJ, Verrij E, Vincent HH, Westerhof BE, Parati G, van Montfrans GA.
How to assess mean blood pressure properly at the brachial artery level.
J Hypertens. 2007;25:751–755. doi: 10.1097/HJH.0b013e32803fb621
29. Karamanoglu M, O’Rourke MF, Avolio AP, Kelly RP. An analysis
of the relationship between central aortic and peripheral upper limb
pressure waves in man. Eur Heart J. 1993;14:160–167. doi: 10.1093/
eurheartj/14.2.160
30. Pauca AL, O’Rourke MF, Kon ND. Prospective evaluation of a method
for estimating ascending aortic pressure from the radial artery pressure
waveform. Hypertension. 2001;38:932–937.
31. Westerhof BE, Guelen I, Westerhof N, Karemaker JM, Avolio A.
Quantification of wave reflection in the human aorta from pressure alone:
a proof of principle. Hypertension. 2006;48:595–601. doi: 10.1161/01.
HYP.0000238330.08894.17
32. Weber T, Ammer M, Rammer M, Adji A, O’Rourke MF, Wassertheurer S,
Rosenkranz S, Eber B. Noninvasive determination of carotid-femoral
pulse wave velocity depends critically on assessment of travel distance:
a comparison with invasive measurement. J Hypertens. 2009;27:1624–
1630. doi: 10.1097/HJH.0b013e32832cb04e
33. Parr JC, Spears GF. General caliber of the retinal arteries expressed
as the equivalent width of the central retinal artery. Am J Ophthalmol.
1974;77:472–477.
34. Hubbard LD, Brothers RJ, King WN, Clegg LX, Klein R, Cooper LS,
Sharrett AR, Davis MD, Cai J. Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in
the Atherosclerosis Risk in Communities Study. Ophthalmology.
1999;106:2269–2280.
35. Knudtson MD, Lee KE, Hubbard LD, Wong TY, Klein R, Klein BE.
Revised formulas for summarizing retinal vessel diameters. Curr Eye Res.
2003;27:143–149.
36. Dewitte K, Fierens C, Stöckl D, Thienpont LM. Application of the BlandAltman plot for interpretation of method-comparison studies: a critical
investigation of its practice. Clin Chem. 2002;48:799–801.
37. Wei FF, Huang QF, Zhang ZY, Van Keer K, Thijs L, Trenson S,
Yang WY, Cauwenberghs N, Mujaj B, Kuznetsova T, Allegaert K,
Struijker-Boudier HAJ, Verhamme P, Vermeer C, Staessen JA. Inactive
matrix Gla protein is a novel circulating biomarker predicting retinal arteriolar narrowing in humans. Sci Rep. 2018;8:15088. doi:
10.1038/s41598-018-33257-6
38. Liew G, Sharrett AR, Kronmal R, Klein R, Wong TY, Mitchell P,
Kifley A, Wang JJ. Measurement of retinal vascular caliber: issues and
alternatives to using the arteriole to venule ratio. Invest Ophthalmol Vis
Sci. 2007;48:52–57. doi: 10.1167/iovs.06-0672
39. Lee HY, Oh BH. Aging and arterial stiffness. Circ J. 2010;74:2257–2262.
40. Boggia J, Luzardo L, Lujambio I, Sottolano M, Robaina S,
Thijs L, Olascoaga A, Noboa O, Struijker-Boudier HA, Safar ME,
Staessen JA. The diurnal profile of central hemodynamics in a general Uruguayan population. Am J Hypertens. 2016;29:737–746. doi:
10.1093/ajh/hpv169
41. Huang N, Foster MC, Mitchell GF, Andresdottir MB, Eiriksdottir G,
Gudmundsdottir H, Harris TB, Launer LJ, Palsson R, Gudnason V, Levey AS,

Wei et al   Retinal Microvasculature and Central Hemodynamics   613

42.

43.
44.

45.

Inker LA. Aortic stiffness and change in glomerular filtration rate and albuminuria in older people. Nephrol Dial Transplant. 2017;32:677–684.
doi: 10.1093/ndt/gfw050
Mitchell GF, van Buchem MA, Sigurdsson S, Gotal JD, Jonsdottir MK,
Kjartansson Ó, Garcia M, Aspelund T, Harris TB, Gudnason V, Launer LJ.
Arterial stiffness, pressure and flow pulsatility and brain structure and
function: the age, gene/environment susceptibility–Reykjavik study.
Brain. 2011;134(pt 11):3398–3407. doi: 10.1093/brain/awr253
Li X, Lyu P, Ren Y, An J, Dong Y. Arterial stiffness and cognitive impairment. J Neurol Sci. 2017;380:1–10. doi: 10.1016/j.jns.2017.06.018
Wei FF, Raaijmakers A, Zhang ZY, van Tienoven TP, Huang QF, Yang WY,
Thijs L, Struijker-Boudier HAJ, Verhamme P, Allegaert K, Staessen JA.
Association between cognition and the retinal microvasculature in 11-year
old children born preterm or at term. Early Hum Dev. 2018;118:1–7. doi:
10.1016/j.earlhumdev.2018.01.018
McGeechan K, Liew G, Macaskill P, Irwig L, Klein R, Klein BE, Wang JJ,
Mitchell P, Vingerling JR, de Jong PT, Witteman JC, Breteler MM, Shaw J,
Zimmet P, Wong TY. Prediction of incident stroke events based on retinal
vessel caliber: a systematic review and individual-participant meta-analysis.
Am J Epidemiol. 2009;170:1323–1332. doi: 10.1093/aje/kwp306

46. Liew G, Sharrett AR, Wang JJ, Klein R, Klein BE, Mitchell P,
Wong TY. Relative importance of systemic determinants of retinal arteriolar and venular caliber: the atherosclerosis risk in communities study. Arch
Ophthalmol. 2008;126:1404–1410. doi: 10.1001/archopht.126.10.1404
47. Wong TY, Klein R, Klein BE, Meuer SM, Hubbard LD. Retinal vessel diameters and their associations with age and blood pressure. Invest
Ophthalmol Vis Sci. 2003;44:4644–4650.
48. Celentano A, Palmieri V, Arezzi E, Mureddu GF, Sabatella M, Di Minno G,
De Simone G. Gender differences in left ventricular chamber and midwall
systolic function in normotensive and hypertensive adults. J Hypertens.
2003;21:1415–1423. doi: 10.1097/01.hjh.0000059088.43904.ba
49. Torjesen AA, Wang N, Larson MG, Hamburg NM, Vita JA, Levy D,
Benjamin EJ, Vasan RS, Mitchell GF. Forward and backward wave
morphology and central pressure augmentation in men and women in
the Framingham Heart Study. Hypertension. 2014;64:259–265. doi:
10.1161/HYPERTENSIONAHA.114.03371
50. Paulus WJ, Tschöpe C. A novel paradigm for heart failure with preserved
ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am
Coll Cardiol. 2013;62:263–271. doi: 10.1016/j.jacc.2013.02.092

Novelty and Significance
What Is New?

•

Stiffening of the large arteries is forerunner of cardiovascular complications and is associated with microvascular disease in kidney and brain.
We hypothesized that the retinal microvascular traits might be associated with central hemodynamic properties. In 735 Flemish, we derived
central pulse pressure and carotid-femoral pulse wave velocity from applanation tonometry and calculated forward (Pf) and backward (Pb) pulse
waves and measured retinal arteriolar and venular caliber and their ratio.

What Is Relevant?

•
•

In unadjusted analyses, smaller central retinal arteriolar caliber was significantly associated with higher central pulse pressure, pulse wave velocity, Pb, and Pf.
With adjustments applied for sex, age, body mass index, brachial diastolic blood pressure, heart rate, serum total cholesterol, plasma glucose,
current smoking and alcohol intake, antihypertensive drug treatment,

•

and history of cardiovascular disease, as appropriate, these associations
remained significant. Associations of arteriole-to-venule diameter ratio
with the central hemodynamic variables mirrored those of central retinal
arteriolar diameter.
In adjusted models, central retinal venular diameter was only associated
with central diastolic blood pressure.

Summary
In the general population, narrower retinal arterial diameter was
associated with central hemodynamic indexes reflecting arterial
stiffness and wave reflections. Our current observations highlight
that dysfunction of the macrocirculation and microcirculation go
hand in hand and suggest that the timely prevention of both macrovascular and microvascular alterations could have relevant clinical
impact.

